Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

HHS-FDA FOR-FD-24-003
Submission: Open Submission

CFDA Numbers

  • 93.103 - Food and Drug Administration Research

Additional Information

Document Type: forecast
Opportunity Category: Discretionary

Related Opportunities